trial · primary record
JNJ-95566692
Lymphoma, Non-Hodgkin
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 340 |
| Primary completion | 2029-10-31 |
| Primary endpoint | Part 1 and 2: Number of Participants with Adverse Events (AEs) And Serious Adverse Events (SAEs) by Severity |
| Registry ID | NCT07308132 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:57.263Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07308132
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.